LIFEVANTAGE CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.69 USD | +3.92% |
|
+1.05% | +28.17% |
| 05-02 | Earnings Flash (LFVN) LIFEVANTAGE CORPORATION Reports Q3 Revenue $48.2M, vs. Street Est of $52.2M | MT |
| 05-02 | Transcript : LifeVantage Corporation, Q3 2024 Earnings Call, May 02, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 97.67M | - | - | - | - | - | |
| 765B | ||||||
| 632B | ||||||
| 354B | ||||||
| 331B | ||||||
| 299B |
